Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults: The ATTICA study

Research output: Contribution to journalArticle

View graph of relations Save citation

Authors

Research units

Abstract

Background and aims
The lipid accumulation product (LAP) is an index describing lipid over-accumulation based on waist circumference (WC) and fasting triglycerides, and can outperform the body mass index (BMI) in recognizing cardiovascular disease (CVD) risk. We aimed to explore the association of LAP with long-term CVD risk and compare its CVD-predictive value against common anthropometric indices/ratios of obesity.

Methods
ATTICA is a prospective, population-based cohort that recruited 3042 adults without pre-existing CVD from the Greek general population (age 18–89 years; 1514 men). The 10-year study follow-up (2011–2012) captured the fatal/non-fatal CVD incidence in 2020 participants (50% men). Baseline LAP (cm⋅mmol/L) was calculated and analyzed in relation to the 10-year CVD incidence.

Results
In total, 317 CVD cases (15.7%) were documented during the follow-up. Baseline LAP showed a significant positive association with the 10-year CVD incidence, even after adjusting for hypertension, diabetes, hypercholesterolemia, smoking, physical activity, Mediterranean diet adherence, and key pro-inflammatory biomarkers (Hazard Ratios per 10 cm mmol/L of LAP ranging from 1.1 to 1.21, p = 0.04). Moreover, LAP predicted the 10-year CVD study incidence better than common obesity indices (BMI, WC, waist-to-hip, waist-to-height ratio).

Conclusions
These findings support and independent positive association between LAP and long-term CVD incidence in CVD-free Caucasian adults from the general population.

Request a copy

Request a copy

Ioannis Kyrou

Person: Academic

Documents

  • Lipid accumulation product in relation to 10-year cardiovascular disease incidence in Caucasian adults

    Rights statement: © 2018, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

    Accepted author manuscript, 758 KB, PDF-document

    Embargo ends: 17/10/19

    Licence: CC BY-NC-ND Show licence

Details

Original languageEnglish
Pages (from-to)10-16
JournalAtherosclerosis
Volume279
Early online date17 Oct 2018
DOIs
Publication statusPublished - 1 Dec 2018

Bibliographic note

© 2018, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

Employable Graduates; Exploitable Research

Copy the text from this field...